Hui Han
- Topics
- Boron Compounds in Chemistry (5 papers)Cancer-related molecular mechanisms research (5 papers)Organoboron and organosilicon chemistry (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hui Han
25 papers receiving 301 citations
Peers
Comparison fields: 5 of 64
- Molecular Biology 141
- Cancer Research 126
- Oncology 86
- Surgery 79
- Pulmonary and Respiratory Medicine 44
Countries citing papers authored by Hui Han
This map shows the geographic impact of Hui Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Han more than expected).
Fields of papers citing papers by Hui Han
This network shows the impact of papers produced by Hui Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Han. The network helps show where Hui Han may publish in the future.
Co-authorship network of co-authors of Hui Han
This figure shows the co-authorship network connecting the top 25 collaborators of Hui Han. A scholar is included among the top collaborators of Hui Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Han. Hui Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | 15 | |
| 5 | 9 | |
| 6 | 7 | |
| 7 | 20 | |
| 8 | 14 | |
| 9 | 2 | |
| 10 | 20 | |
| 11 | 4 | |
| 12 | 20 | |
| 13 | 9 | |
| 14 | 14 | |
| 15 | Prognostic significance of high-risk human papillomavirus and p16(INK4A) in patients with esophageal squamous cell carcinoma. | 23 |
| 16 | Clinical curative effect and safety of therapy of supplementing qi and activating blood on acute ischemia stroke(syndrome of qi deficiency and blood stasis): a Meta-analysis | 1 |
| 17 | 17 | |
| 18 | 60 | |
| 19 | [Expression and clinical significance of survivin and PTEN in adrenal tumors]. | 3 |
| 20 | Performance status and age as independent predictors of survival among AIDS patients with primary CNS lymphoma: a multivariate analysis of a multi-institutional experience. | 14 |
About Hui Han
Hui Han is a scholar working on Cancer Research, Otorhinolaryngology and Toxicology, having authored 25 papers that have together received 310 indexed citations. Recurring topics across this work include Boron Compounds in Chemistry (5 papers), Cancer-related molecular mechanisms research (5 papers) and Organoboron and organosilicon chemistry (4 papers). The work is most often cited by research in Cancer Research (126 citations), Otorhinolaryngology (21 citations) and Oncology (86 citations). Hui Han has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Fangli Cao, Xi-sheng Leng, Pengcheng Chen, Yufeng Cheng, Jirun Peng, Fang Zhang, Lei Gong, Juan Zhou, Huimin Li and Meirong Liu. Their work appears in journals such as Oncogene, Chemical Communications and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.